Home › Funds › Patient Square Capital LP › ABVX

Patient Square Capital LP position in ABVX

ABIVAX SA · Health Care

Patient Square Capital LP reported holding 243,000 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$24.1M, representing 3.84% of its reported portfolio and ranking #6 among its reported holdings. Patient Square Capital LP has disclosed ABVX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)243.00K sh
Reported value held$24.06M
Portfolio Weight3.84%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's ABVX position evolved

Patient Square Capital LP first disclosed a stake in ABVX in Q3 2025 at 151,833 shares (US$12.9M). The position peaked in Q2 2026 at 206,500 shares, worth US$27.5M. Across 5 filings, Patient Square Capital LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 243,000 shares valued at US$24.1M — an increase of 36,500 shares quarter over quarter.. Notable position changes include a 70% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 151.83K $12.89M New
Q4 2025 130.00K $17.53M Reduce
Q1 2026 121.25K $13.50M Reduce
Q2 2026 206.50K $27.52M Add
Q3 2026 243.00K $24.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 70 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Patient Square Capital LP held ABVX?

Patient Square Capital LP has disclosed ABVX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Patient Square Capital LP's current position in ABVX?

As of Q3 2026, Patient Square Capital LP holds 243.00K shares of ABVX (ABIVAX SA), valued at $24.06M, representing 3.84% of its reported portfolio and ranking #6.

Has Patient Square Capital LP been buying or selling ABVX?

In the latest 13F filing (Q3 2026), Patient Square Capital LP increased its position in ABVX. The position peaked in Q2 2026 at 206.50K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.